Investing in Helus Pharma involves purchasing publicly traded shares of the company through a licensed brokerage account, as its common stock is listed on major public exchanges including the NASDAQ Global Market and Cboe Canada under the ticker symbol HELP. To execute a trade, an investor must set up an active brokerage account, fund the balance, and search for the HELP ticker symbol during standard market trading hours. Because clinical-stage biotechnology equities carry high volatility and speculative risks tied to clinical trial outcomes and regulatory decisions, prospective investors should carefully review their personal risk tolerances, examine financial reports, and consult licensed financial advisors before committing capital.